title: Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
authors.affiliation: Division of Medical Oncology, British Columbia Cancer Agency, Vancouver General Hospital, British Columbia Cancer Agency, and the University of British Columbia, Vancouver, BC, Canada.
authors.forename: Abdulwahab J
authors.initials: AJ
authors.lastname: Al-Tourah
authors.forename: Peter W K
authors.initials: PW
authors.lastname: Tsang
authors.forename: Brian F
authors.initials: BF
authors.lastname: Skinnider
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Hoskins
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004921:Erythropoietin / Q000097:blood; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000209:etiology* / Q000628:therapy; D018962:Phlebotomy; D011086:Polycythemia / Q000097:blood / Q000209:etiology* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D004921:Erythropoietin; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone